US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 5.100
- +0.330+6.92%
Trading Jul 26 14:00 ET
182.17MMarket Cap-7402P/E (TTM)
5.240High4.640Low98.65KVolume4.750Open4.770Pre Close489.33KTurnover0.43%Turnover RatioLossP/E (Static)35.72MShares55.00052wk High-47.22P/B115.82MFloat Cap3.90052wk Low--Dividend TTM22.71MShs Float55.000Historical High--Div YieldTTM12.58%Amplitude3.900Historical Low4.960Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
FibroBiologics Stock Forum
The rest of stock continue to fall on a friday
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
FibroBiologics (Nasdaq: FBLG), a clinical-stage biotech company, has developed a novel artificial thymus organoid capable of restoring immune function in severe combined immunodeficiency (SCID) mouse models. This organoid is made from fibroblasts and thymus-derived cells and can produce mature and diverse T cells, including CD4, CD8, and regulatory T cells. The comp...
$BiomX(PHGE.US)$ $Larimar Therapeutics(LRMR.US)$ $Clene(CLNN.US)$ $Glucotrack(GCTK.US)$ $Sonnet BioTherapeutic(SONN.US)$ $FibroBiologics(FBLG.US)$ $NanoString Technologies(NSTGQ.US)$
📊⚡️📊
No comment yet